Fukuda Denshi Co Ltd - Company Profile
Powered by 
All the sales intelligence you need on Fukuda Denshi Co Ltd in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how Fukuda Denshi Co Ltd fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with Fukuda Denshi Co Ltd.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Related keylists
Fukuda Denshi Co Ltd (Fukuda Denshi) specializes in the development and distribution of medical equipment. The company's primary activities include the production and sale of physiological diagnostic equipment, medical treatment equipment, patient monitoring equipment, and consumables and other products. Its major products include electrocardiographs, ultrasound diagnostic imaging systems, blood-cell counters, patient monitors, defibrillators, ventilators, pacemakers, and catheters. The company's products are used in various healthcare settings, from hospitals to home care, for prevention, testing, treatment, and rehabilitation. The company distributes its products through direct sales force in Japan, the US, the UK, China, and Singapore, and through a network of distributors in the Americas, Europe, Africa and Asia. Fukuda Denshi is headquartered in Bunkyo-Ku, Tokyo, Japan.
Headquarters
Japan
Address
2-35-8, Hongo, Bunkyo-Ku, Tokyo, 113-8420
Website
www.fukuda.co.jp
Telephone
81 3 38152121
No of Employees
3,465
Industry
Medical Equipment
Ticker Symbol & Exchange
6960 (TYO)
Revenue (2025)
$962.0M
-0.9%
(2025 vs 2024)
EPS
XYZ
Net Income (2025)
XYZ
-0.5%
(2025 vs 2024)
Market Cap*
$2.8B
Net Profit Margin (2025)
XYZ
0.5%
(2025 vs 2024)
* As of and is in US$
Fukuda Denshi Co Ltd premium industry data and analytics
Products and Services
| Products |
|---|
| Cardiology: |
| Resting ECG |
| Stress Test |
| XYZ |
| XYZ |
| XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2025 | Contracts/Agreements | In May, the company entered into an agreement to acquire a 51% stake in M. Heart Co. Ltd. from CAC Corporation. |
| 2024 | Contracts/Agreements | In June, the company's subsidiary Fukuda Denshi USA entered into a purchasing agreement with Premier Inc for physiological monitoring systems. |
| 2024 | New Products/Services | In February, the company launched the integrated TetraGraph module in Japan. |
Competitor Comparison
| Key Parameters | Fukuda Denshi Co Ltd | Sysmex Corp | Nihon Kohden Corp | CONMED Corp | Menicon Co Ltd |
|---|---|---|---|---|---|
| Headquarters | Japan | Japan | Japan | United States of America | Japan |
| City | Bunkyo-Ku | Kobe | Shinjuku-Ku | Largo | Nagoya-Shi |
| State/Province | Tokyo | Hyogo | Tokyo | Florida | Aichi |
| No. of Employees | 3,465 | 11,457 | 6,114 | 3,900 | 4,325 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Kotaro Fukuda | Chairman | Executive Board | 2012 | 81 |
| Daijiro Shirai | Director; President; Chief Operating Officer | Executive Board | 2023 | 75 |
| Haruo Ogawa | Managing Director; Director | Executive Board | - | 69 |
| Kazuo Genchi | Director; Managing Director | Executive Board | 2023 | 66 |
| Naoki Kuno | Manager Director; President | Senior Management | 2023 | 58 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer